What is Molecular profiling?

Molecular profiling (also called tumor profiling or genomic profiling) is a laboratory process that analyzes the genetic, epigenetic, and protein features of a tumor. The goal is to understand what is driving a cancer at the molecular level and use that information to guide personalized treatment decisions.

It goes beyond simply identifying the cancer’s tissue of origin — it reveals mutations, biomarkers, and pathways that make each patient’s cancer unique.

 

How Molecular Profiling Is Used in Cancer

1. Diagnosis & Subtyping

• Distinguishes between cancer subtypes that may look similar under a microscope.
• Example: Identifying HER2-positive vs. HER2-negative breast cancer.

2. Treatment Selection (Precision Oncology)

• Detects actionable mutations or biomarkers that match targeted therapies or immunotherapies.
• Examples:
  • EGFR, ALK, ROS1 in lung cancer → targeted inhibitors.
  • MSI-H (microsatellite instability-high) or PD-L1 expression → immunotherapy.

3. Prognosis

• Certain genetic profiles can indicate whether a cancer is aggressive or indolent.
• Example: Oncotype DX (gene expression profile) predicts breast cancer recurrence risk.

4. Monitoring & Resistance

• Detects new mutations that develop after treatment.
• Explains why certain therapies stop working and suggests alternatives.

5. Clinical Trials

• Identifies patients who may benefit from targeted experimental therapies in research studies.

 

What Tests Are Used in Molecular Profiling?

• Next-Generation Sequencing (NGS): Reads many genes at once.
• Immunohistochemistry (IHC): Detects protein expression (e.g., HER2, PD-L1).
• Fluorescence In Situ Hybridization (FISH): Detects chromosomal changes.
• PCR (Polymerase Chain Reaction): Amplifies DNA to detect specific mutations.
• Liquid Biopsy: Uses blood samples to profile ctDNA or CTCs.

 

What to Expect During the Test

• Requires tumor tissue biopsy or sometimes a blood sample (liquid biopsy).
• DNA, RNA, or proteins are extracted and analyzed in specialized labs.
• Results typically take 1–3 weeks.
• Reports include a list of mutations and possible matching treatments.

 

Benefits

• Enables personalized treatment instead of one-size-fits-all.
• May reveal new therapy options when standard treatments fail.
• Helps avoid unnecessary or ineffective treatments.
• Opens access to clinical trials based on biomarkers.

 

Risks & Limitations

• Not all cancers have actionable mutations.
• Some detected mutations have no current approved treatment.
• Interpretation requires expert review.
• Cost and insurance coverage may vary by country.
• Tissue sample quality (or lack of tumor DNA in blood) can limit results.

 

Alternatives & Related Approaches

• Traditional pathology: Examines tumor cells under a microscope (not molecular).
• Tumor markers in blood (CEA, CA-125, PSA): Useful but less precise.
• Standard imaging: Shows tumor size and spread, not biology.

 

Questions to Ask Your Doctor

• What type of molecular profiling do you recommend for my cancer?
• Which mutations or biomarkers will the test check for?
• How will the results change my treatment plan?
• Should I consider retesting if my cancer changes?
• Is this covered by insurance, or should I explore clinical trial testing options?

 

Patient Tips

• Keep copies of your molecular profiling reports — they are vital for long-term care.
• If results show no actionable mutations, ask if clinical trials are an option.
• Consider genetic counseling if hereditary mutations are found.
• Remember: molecular profiling is a tool — decisions are still made in the context of your overall health and cancer type.

 

References

• National Cancer Institute (NCI): Molecular Profiling and Cancer Treatment
• American Cancer Society: Precision Medicine in Cancer Treatment
• ASCO (American Society of Clinical Oncology): Biomarker Testing for Cancer